Canada markets closed

Novavax, Inc. (NVAX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
134.56-4.23 (-3.05%)
At close: 4:00PM EDT
133.50 -1.06 (-0.79%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close138.79
Open138.46
Bid133.00 x 1200
Ask133.65 x 1000
Day's Range130.64 - 138.60
52 Week Range76.59 - 331.68
Volume3,105,882
Avg. Volume5,413,210
Market Cap10.023B
Beta (5Y Monthly)1.59
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Motley Fool

    Are Atea Pharmaceuticals, Agenus, Novavax, and Ocular Therapeutix Bad News Buy?

    Biotech stocks are in a slump. Despite numerous wins in the high-profile areas of COVID-19 and cancer therapy, the industry has failed to excite investors this year -- as seen in the 12% year-to-date fall in the the bellwether SPDR S&P Biotech ETF. Risk-tolerant growth investors appear to be favoring other vehicles over biotech in 2021, such as the red-hot cryptocurrency Shiba Inu (CRYPTO: SHIB), electric-vehicle giant Tesla (NASDAQ: TSLA), and emerging social media plays such as Digital World Acquisition (NASDAQ: DWAC) and Phunware (NASDAQ: PHUN).

  • Motley Fool

    Why Novavax Fell by 3% Today

    Good news for a rival's coronavirus vaccine compounds worries about the company's shot.

  • Yahoo Finance Video

    Logistics and distribution key to fighting COVID-19 worldwide, says former commerce secretary.

    Gary Locke, former U.S. Commerce Secretary, talks vaccine distribution, intellectual property, and why cold storage and personnel are critical to fighting COVID-19 around the world.